A study by Hong Kong Baptist University shows that a multifunctional organic compound called F-Sloh has the potential to treat early Alzheimer's disease (commonly known as Alzheimer's disease).
According to the Hong Kong News Agency, the Baptist University announced the results of the research on Wednesday (August 24).
Alzheimer's disease is the most common cause of cognitive disorder, accounting for 65%of Chinese elders in Hong Kong's cognitive disorder.There is no healing method at present, and the drugs that are using can only relieve symptoms.
F-SLOH is a multi-functional anthocyanins synthesized by Professor Huang Wencheng's team to detect biomass such as protein and peptides.
A research team consisting of Li Min, deputy dean of the School of Traditional Chinese Medicine and professor of teaching and research department, found that the compound can inhibit the accumulation of amyloidin β (Aβ) of the brain nerve cells and reduce the nerveInflammation can improve the pathological characteristics of Alzheimer's disease.
In order to evaluate the effectiveness of F-SLOH treatment of Alzheimer's disease, the researchers injected or fed the F-SLOH to a set of GMG Alzheimer's mice and foundPathological characteristics can also improve memory and cognitive functions.
Li Min said that with the aging of the Hong Kong population, the prevalence of Alzheimer's disease will further increase, so there is an urgent need to develop new drugs to treat or slow the deterioration of Alzheimer's disease.Essence
